Knee osteoarthritis. Osteoarthritis of knee, unspecified
Conditions
Interventions
Intervention 1: Control group: Treatment in this group includes taking 15 mg of meloxicam daily for 15 days, as well as educating patients in the clinic on lifestyle modifications and exercises suitab
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Filling and signing the consent form Having pain and other clinical manifestations of knee osteoarthritis in the last month Being between 40 to 60 years old Not having any periarticular disease around the joint in question
Exclusion criteria
Exclusion criteria: High grade arthritis according to radiology Presence of diabetes mellitus Presence of rheumatologic and collagen vascular diseases such as gout and lupus Presence of concomitant radiculopathy Presence of neural damage and neuropathy Presence of brucellosis Presence of any malignancy Presence of a history of significant liver disease Presence of a history of significant liver disease Presence of a history of significant kidney disease Presence of a history of significant cardiac disease Presence of a history of significant pulmonary disease A body mass index greater than 42 Presence of a history of knee joint replacement in the knee being studied Presence of a history of trauma or fracture in the knee being studied Presence of bleeding disorders Presence of an inability to communicate and to complete questionnaires Presence of a history of allergic or hypersensitivity reaction to the drugs being used Presence of a history of injections in the last 3 months within or around the joint being studied Presence of a state of pregnancy or lactation Patients taking anticoagulant medications Presence of a history of gastrointestinal and stomach disease Use of warfarin and ticlopidine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain caused by knee osteoarthritis. Timepoint: Before starting the intervention; 2, 4, and 8 weeks later. Method of measurement: Visual analog scale; Western Ontario and McMaster Universities Arthritis Index; Oxford knee scale; Patient satisfaction. | — |
Secondary
| Measure | Time frame |
|---|---|
| Degree of knee dysfunction. Timepoint: Before starting the intervention; 2, 4, and 8 weeks later. Method of measurement: Western Ontario and McMaster Universities Arthritis Index; Oxford knee scale; Patient satisfaction. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Haghighat
Shiraz University of Medical Sciences
Outcome results
None listed